IRCT2017073135415N1
Assesment of "Dawa al-Blaghm" on liver enzymes in patients with fatty liver
Evaluation of the effect of Dva’-Albalgham ,on serum levels of liver enzymes in patients with NAFLD.
Vice chancellor for research, Qom University of Medical Sciences·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Nonalcoholic fatty liver disease (NAFLD)
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Vice chancellor for research, Qom University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 21, 2017
- End date
- N/A
ICD-10 classifications
Liver disease, unspecifiedInflammatory liver disease, unspecifiedAlcoholic liver disease, unspecifiedAlcoholic fatty liverToxic liver disease, unspecified
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT2017073135415N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT2017073135415N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Vice chancellor for research, Qom University of Medical Sciences and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.